Pharma Hikma Reaches $150M Opioid Settlement With States
Hikma Pharmaceuticals and several attorneys general announced a $150 million agreement in principle on Thursday resolving cases brought by a group of states and localities alleging the company fueled the opioid...To view the full article, register now.
Already a subscriber? Click here to view full article